In addition, relapse-free survival rates of breast cancers (both HER2+ and HER2−) were negatively correlated with the level of Twist1, but positively correlated with BTG2 expression by open data analysis (Fig. 7b, c). The gene discussed is TWIST1; the disease is breast carcinoma.